Polysaccharide Vaccines
Polysaccharide vaccines play a critical role in preventing diseases caused by encapsulated bacteria, such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. These vaccines are in complex polysaccharide protein conjugate molecules that stimulate the immune system and provide long-lasting protection.
In this webinar, we will explore analytical techniques used to evaluate the efficacy, safety, and quality of polysaccharide vaccines.
Key learning objectives:
- Understand regulatory perspectives and the resources provided by USP for the characterization of polysaccharide vaccines
- Explore the benefits of LC coupled with Multi-Angle Light Scattering (MALS) as a quality attribute
Who should attend:
- Analytical scientists involved with the characterization of polysaccharide vaccines.
Presenter: Mandy Alger (Senior Scientist II, Global Biologics US Pharmacopeia)
Mandy has been working on biopharmaceuticals and vaccine development for more than twenty years. Prior to her tenure at the United States Pharmacopeia, she was employed by organizations like GlaxoSmithKline (GSK), the National Institutes of Health (NIH), and AstraZeneca (AZ).Joined the Global Biologics Division of USP in 2021 and currently serves as a Senior Scientist II at USP. Collaborates with the USP teams, the pharmaceutical industry, and the FDA to develop USP reference standards and documentation standards pertaining to pharmaceuticals, includingcomplex Proteins, Heparin, Dextran, Oxytocin, Oligosaccharide, and polysaccharide vaccine molecular weight standards.
Presenter: Katayoun Morakabi, Ph.D. (Application Scientist Waters l Wyatt Technology)
Katayoun Morakabi is an application scientist in the Analytical Sciences team at Waters | Wyatt Technology. She assists customers in identifying the best light scattering solutions for their analytical needs by leveraging her expertise in multi-angle light scattering. She performs feasibility studies to characterize customer samples and participates in Wyatt’s Light Scattering University. She completed her Ph.D. in Biochemistry from the University of Texas at Dallas. Her doctoral work focused on characterizing the structure, dynamics, and functional outcomes of histone acetyltransferases and histone chaperone proteins.
Moderator: Isabelle Vu Trieu (Pharmaceutical Market Development Manager, Americas, Waters Corporation)
Isabelle is a business development professional dedicated to delivering benefits to analytical scientists in the life sciences industry. With over 20 years of experience in providing chromatography and mass spectrometry solutions, Isabelle is particularly interested in helping pharmaceutical scientists achieve the data quality and integrity needed to drive decisions for drug quality, safety and efficacy. Isabelle joined Waters in 2009 and currently manages the development of the pharmaceutical market in the Americas. She holds Masters’ degrees in Chemistry from Columbia University and the University Claude Bernard in Lyon, France as well as a Chemical Engineering degree from Ecole Supérieure de Chimie Physique Electronique in Lyon, France.
